← Insider buys
CUE

Cue Biopharma, Inc. · Healthcare

Director Anthony Digiandomenico bought $55K of Cue Biopharma, Inc.

Bought$54,800
$5.48Price
10,000Shares

What CUE did for a copier

Prices for CUE after this filing aren't in yet.

Anthony Digiandomenico's record

11 other buys on record. A record shows here once 3 of them have 3 months of prices.

We're building an app that can copy buys like this into your own brokerage. Join the waitlist

Traded Mon, Dec 17. Filed Tue, Dec 18, 11:31 AM ET, during the session. Not investment advice.